Search is not available for this dataset
image image | ocr_annotation_texts string | image_height int64 | image_width int64 |
|---|---|---|---|
9 5 14 1 Breast Cancer Research 24 5 15 1 et al. Vol 6 No 6 32 5 5 1 Kitayama 9 10 39 1 Previous studies also found that malignant transformation 51 10 39 1 total RNA was reverse transcribed using a SuperScript 9 11 39 1 resulted in aberrant expression of LPA2 or LPA3 in ovarian 51 11 39 1 First-Strand Synthesis System... | 1,000 | 771 | |
50 5 40 1 http://breast-cancer-research.com/content/6/6/R640 Available online 9 10 4 1 Table 2 9 12 68 1 The relationship between lysophosphatidic acid receptor 2 (LPA2) expression and clinical/pathological factor 9 15 62 1 P LPA2 expression 30 15 5 1 Low (36) 50 15 5 1 High (48) 9 17 6 1 Age (years) 11 19 2 1 <50 30 1... | 1,000 | 771 | |
51 5 39 1 http://breast-cancer-research.com/content/7/1/R46 Available online 9 10 4 1 Table 1 9 12 79 1 5-Bromo-2'-deoxyuridine (BrdU) labeling* of MCF10A cells grown in monoculture (control group) and in co-cultures with normal 9 14 50 1 breast-associated fibroblasts (NAF) and carcinoma-associated fibroblasts (CAF) 9 ... | 1,000 | 771 | |
9 5 14 1 Breast Cancer Research 24 5 16 1 et al. Vol 7 No 1 32 5 5 1 Sadlonova 9 10 4 1 Table 2 9 12 81 1 5-Bromo-2'-deoxyuridine (BrdU) labeling* of MCF10AT cells grown in monoculture and in co-cultures with normal breast-associated 9 14 38 1 fibroblasts (NAF) and carcinoma-associated fibroblasts (CAF) 9 16 3 1 Cultur... | 1,000 | 771 | |
51 5 39 1 http://breast-cancer-research.com/content/7/1/R46 Available online 9 10 4 1 Table 3 9 12 80 1 Insulin-like growth factor (IGF) II ELISA for normal breast-associated fibroblasts (NAF), carcinoma-associated fibroblasts (CAF), 9 14 34 1 MCF10A cells and MCF10AT cells in monolayer cultures 9 16 4 1 Cell type 52 1... | 1,000 | 771 | |
9 5 14 1 Breast Cancer Research 24 5 14 1 et al. Vol 7 No 1 32 5 3 1 Davies 9 10 4 1 Table 1 9 12 9 1 Case selection 9 15 5 1 Parameter 37 15 3 1 Detail 75 15 3 1 Value 9 17 6 1 Age (years) 37 17 3 1 Range 75 17 3 1 48–88 9 19 5 1 Histology 37 19 8 1 Invasive ductal 76 19 2 1 115 37 21 8 1 Invasive lobular 76 21 1 1 11... | 1,000 | 771 | |
50 5 40 1 http://breast-cancer-research.com/content/7/2/R204 Available online 9 10 4 1 Table 1 9 12 40 1 Single-nucleotide polymorphisms (SNPs) selected for genotyping 9 15 6 1 SNP name 30 15 5 1 dbSNP id 50 15 4 1 Location 77 15 7 1 Base change 9 17 3 1 SNP 1 30 17 6 1 rs4252596 50 17 7 1 START -657a 79 17 3 1 C>Ab 9 ... | 1,000 | 771 | |
9 5 14 1 Breast Cancer Research 24 5 16 1 et al. Vol 7 No 2 32 5 5 1 Benusiglio 9 10 4 1 Table 2 9 12 64 1 Genotype frequencies and genotype-specific risks in 2192 women with breast cancer and 2257 controls 9 15 75 1 P SNP 17 15 3 1 Series 29 15 5 1 Rare-allele 37 15 10 1 Common homozygote 49 15 8 1 Heterozygote No. 60... | 1,000 | 771 | |
9 5 17 1 Arthritis Research & Therapy 27 5 13 1 et al. Vol 7 No 1 35 5 2 1 Giles 9 10 4 1 Table 1 9 12 70 1 The range of IgG concentrations (ng/ml) produced by expression of the 32 heavy chain/light chain combinations 9 15 6 1 Heavy chain 19 15 16 1 Light chain contributing CDR1 37 15 23 1 Light chain contributing CDR2... | 1,000 | 771 | |
55 5 35 1 Available online http://ccforum.com/content/8/6/R385 9 10 4 1 Table 1 9 12 74 1 Demographic data, duration of use of endotracheal tube and pediatric airway exchange catheter, and reintubation ratio 9 15 45 1 (n Parameter 50 15 3 1 Value 55 15 3 1 = 36) 9 17 5 1 Sex (F/M) 50 17 11 1 28/8 (77.8%/22.2%) 9 19 6 1... | 1,000 | 771 | |
55 5 35 1 Available online http://ccforum.com/content/8/6/R422 9 10 4 1 Table 1 9 12 29 1 Demographic data of the patients investigated 9 15 5 1 Parameter 68 15 3 1 Value 9 17 10 1 Number of patients 69 17 2 1 106 9 19 6 1 Age (years) 67 19 6 1 66.6 ± 18.3 9 21 15 1 (n) Ratio of males to females 68 21 3 1 88/18 9 23 9 ... | 1,000 | 771 | |
9 5 8 1 Critical Care 19 5 10 1 December 2004 31 5 6 1 Vol 8 No 6 40 5 9 1 Camargo et al. 9 10 4 1 Table 2 9 12 40 1 Clinical characteristics of the patients in the events investigated. 9 15 5 1 Parameter 44 15 11 1 Total evaluations (%) 69 15 16 1 Evaluations in VAP group (%) 9 17 12 1 Number of evaluations 46 17 6 1 ... | 1,000 | 771 | |
55 5 35 1 Available online http://ccforum.com/content/8/6/R422 9 10 4 1 Table 3 9 12 22 1 Qualitative and quantitative analysis 9 15 5 1 Parameter 36 15 5 1 Qualitative 67 15 6 1 Quantitative 57 17 5 1 105 cfu/ml 77 17 5 1 106 cfu/ml 9 19 5 1 Sensitivity 38 19 2 1 81% 58 19 2 1 65% 79 19 2 1 26% 9 21 5 1 Specificity 38... | 1,000 | 771 | |
9 5 8 1 Critical Care 19 5 10 1 December 2004 31 5 6 1 Vol 8 No 6 40 5 9 1 Camargo et al. 9 10 4 1 Table 5 9 12 33 1 Prescription of antimicrobials in all the events studied 9 15 63 1 (n Class of antimicrobial 65 15 6 1 Evaluations 73 15 2 1 [%]) 9 17 7 1 Glycopeptide 66 17 7 1 109 (49.7%) 9 19 6 1 Antifungical 67 19 6... | 1,000 | 771 | |
9 5 8 1 Critical Care 19 5 9 1 February 2005 30 5 6 1 Vol 9 No 1 39 5 10 1 Prinianakis et al. 9 10 4 1 Table 1 9 12 44 1 Baseline ventilator settings and patients' respiratory system mechanics 23 15 1 1 VT 50 15 1 1 Crs 64 15 1 1 Rint 9 15 69 1 Rrs No. 37 15 1 1 Fr 9 17 0 1 1 23 17 2 1 0.68 37 17 2 1 12.8 50 17 2 1 47.... | 1,000 | 771 | |
9 5 8 1 Critical Care 19 5 9 1 February 2005 30 5 6 1 Vol 9 No 1 39 5 10 1 Prinianakis et al. 9 10 4 1 Table 3 9 12 14 1 Model study: protocol B 21 15 0 1 R 44 15 0 1 R 9 15 59 1 R Parameter 22 15 1 1 = 8 45 15 2 1 = 16 69 15 2 1 = 32 21 16 1 1 C 28 16 1 1 C 36 16 1 1 C 44 16 1 1 C 52 16 1 1 C 60 16 1 1 C 68 16 1 1 C 7... | 1,000 | 771 | |
54 5 36 1 http://arthritis-research.com/content/7/2/R349 Available online 9 10 4 1 Table 1 9 12 66 1 Clinical and demographic characteristics of patients with rheumatoid arthritis (RA) and of healthy controls 47 15 1 1 (n 66 15 1 1 (n 40 15 42 1 (n Erosive RA 48 15 3 1 = 88) 57 15 8 1 Non-erosive RA 67 15 3 1 = 43) 77 ... | 1,000 | 771 | |
8 5 15 1 BMC Cancer 2005, 5:30 60 5 30 1 http://www.biomedcentral.com/1471-2407/5/30 8 10 39 1 supportive care was applied consisting of antiemetic med- 51 10 27 1 Table 1: Characteristics of Patients (N = 180) 8 12 39 1 ication with 5HT3 antagonist on the days of chemo, anti- 51 13 12 1 Median age (range), yrs 77 13 5... | 1,000 | 771 | |
8 5 15 1 BMC Cancer 2005, 5:30 60 5 30 1 http://www.biomedcentral.com/1471-2407/5/30 8 10 37 1 Table 2: Worst degree of toxicity by age group (% of patients) 9 12 56 1 ≥ Type of toxicity 36 13 15 1 >60 and <65 years (n = 100) 66 13 9 1 65 years (n = 80) 86 13 1 1 P* 34 15 0 1 0 40 15 0 1 1 45 15 0 1 2 50 15 0 1 3 54 15... | 1,000 | 771 | |
8 5 15 1 BMC Cancer 2005, 5:30 60 5 30 1 http://www.biomedcentral.com/1471-2407/5/30 8 10 48 1 Table 3: Worst degree of hematological toxicity by radiotherapy (% of patients) 9 13 8 1 Type of toxicity 38 13 7 1 No (n = 114) 63 13 6 1 Yes (n = 66) 84 13 1 1 P* 33 15 0 1 0 38 15 0 1 1 43 15 0 1 2 47 15 0 1 3 51 15 0 1 4 ... | 1,000 | 771 | |
8 5 15 1 BMC Cancer 2005, 5:30 60 5 30 1 http://www.biomedcentral.com/1471-2407/5/30 8 10 45 1 Table 5: Pattern of compliance to chemotherapy by age and radiotherapy 9 13 4 1 Variable 49 13 2 1 Age 74 13 7 1 Radiotherapy 36 15 16 1 ≥ >60 and < 65 (n 47 15 2 1 100) 54 15 2 1 65 (n 58 15 1 1 80) 63 15 1 1 P§ 67 15 3 1 No... | 1,000 | 771 | |
8 5 28 1 BMC Health Services Research 2005, 5:22 60 5 30 1 http://www.biomedcentral.com/1472-6963/5/22 8 10 39 1 added to wait lists, they were not included in analyses of 51 10 38 1 Table 1: Characteristics of 9,231 subjects registered for isolated 8 11 81 1 coronary artery bypass surgery in British Columbia, 1991–200... | 1,000 | 771 | |
8 5 28 1 BMC Health Services Research 2005, 5:22 60 5 30 1 http://www.biomedcentral.com/1472-6963/5/22 8 10 79 1 Table 2: Distribution of subjects registered for isolated coronary artery bypass surgery in British Columbia, 1991–2000, by priority 8 11 18 1 group and registration period 9 14 7 1 Registration 29 14 5 1 Pr... | 1,000 | 771 | |
8 5 28 1 BMC Health Services Research 2005, 5:22 60 5 30 1 http://www.biomedcentral.com/1472-6963/5/22 8 10 80 1 Table 3: Percentiles of wait-list time (weeks) for subjects registered for isolated coronary artery bypass surgery in British Columbia 8 11 20 1 1991–2000 by registration period 9 14 12 1 Registration period... | 1,000 | 771 | |
8 5 28 1 BMC Health Services Research 2005, 5:22 60 5 30 1 http://www.biomedcentral.com/1472-6963/5/22 8 10 81 1 Table 5: Access to surgery by registration period and priority group for subjects registered for isolated coronary artery bypass surgery 8 11 43 1 in British Columbia 1991–2000, as measured by adjusted hazar... | 1,000 | 771 | |
8 5 28 1 BMC Health Services Research 2005, 5:22 60 5 30 1 http://www.biomedcentral.com/1472-6963/5/22 8 10 78 1 Table 6: Distributions of patients who were registered on wait lists or operated without delay in British Columbia 1991–2000, by 8 11 11 1 registration period 9 14 12 1 Registration Period 46 14 22 1 Patient... | 1,000 | 771 | |
8 5 20 1 BMC Neuroscience 2005, 6:20 60 5 30 1 http://www.biomedcentral.com/1471-2202/6/20 8 10 15 1 Table 1: Antibodies used 9 13 3 1 Marker 32 13 4 1 Species 43 13 9 1 Working dilution 57 13 11 1 Vendor or productor 9 15 8 1 Proliferation 9 17 2 1 BrdU 32 17 5 1 Mouse IgG 43 17 2 1 1:500 57 17 16 1 Novo Castra (Newca... | 1,000 | 771 | |
8 5 15 1 BMC Urology 2005, 5:5 61 5 29 1 http://www.biomedcentral.com/1471-2490/5/5 8 10 81 1 Table 1: Highly expressed Casodex responsive genes in the LNCaP model. Data show fold-increase in gene expression over reference 8 11 51 1 samples. Each datum point represents mean ± SE from 3 independent experiments. 55 14 5 ... | 1,000 | 771 | |
8 5 15 1 Filaria Journal 2005, 4:1 63 5 27 1 http://www.filariajournal.com/content/4/1/1 8 10 55 1 Table 1: Number of nodules palpated vs. number of nodules detected by ultrasound (USG). 33 12 13 1 Male patients N = 44 52 12 14 1 Female patients N = 17 76 12 7 1 Total N = 61 9 15 2 1 USG 38 15 2 1 303 59 15 1 1 98 79 1... | 1,000 | 771 | |
8 5 15 1 Filaria Journal 2005, 4:1 63 5 27 1 http://www.filariajournal.com/content/4/1/1 8 10 81 1 Table 2: Total numbers of male and female patients with onchocercomas, in which motile or non-motile adult worms were detected 8 11 13 1 by ultrasound (USG). 49 14 8 1 Male patients 64 14 10 1 Female patients 82 14 3 1 To... | 1,000 | 771 | |
8 5 18 1 Nutrition Journal 2005, 4:12 64 5 25 1 http://www.nutritionj.com/content/4/1/12 11 11 44 1 120 1.1 11 13 1 0 1.0 54 14 1 0 100 12 15 0 0 .9 55 17 1 0 80 12 17 0 0 .8 9 18 1 3 Survival 52 18 1 3 patients 12 19 0 0 .7 55 20 1 0 60 84 21 2 1 SEX 9 21 1 4 Cumulative 12 21 0 0 .6 52 22 1 0 of 52 23 4 3 40 Number 86... | 1,000 | 771 | |
8 5 18 1 Nutrition Journal 2005, 4:12 64 5 25 1 http://www.nutritionj.com/content/4/1/12 51 10 39 1 stages of presentation in the three periods (Chi2 = 7.2, df 13 11 18 1 Nutritional status on presentation 51 12 9 1 = 4, p = 0.13). 11 13 1 0 60 51 15 19 1 Nutritional status of patients 11 16 1 0 50 51 16 39 1 The mean ... | 1,000 | 771 | |
8 5 18 1 Nutrition Journal 2005, 4:12 64 5 25 1 http://www.nutritionj.com/content/4/1/12 8 10 54 1 Table 4: Rate of change of nutritional status of 22 patients who survived all three surveys 56 13 2 1 Mean 69 13 7 1 Std. Deviation 86 13 1 1 N 9 15 39 1 change in BMI per 100 days from initial assessment to June 2003 sur... | 1,000 | 771 | |
8 5 18 1 Nutrition Journal 2005, 4:12 64 5 25 1 http://www.nutritionj.com/content/4/1/12 8 10 81 1 Table 6: Mean Body Mass Index of households all ages comparing two groups, one surveyed (in June 2003) before and the other (in July 8 11 17 1 2004) after food distribution 23 14 3 1 Group 42 14 1 1 N 55 14 2 1 Mean 66 14... | 1,000 | 771 | |
8 5 19 1 BMC Medical Ethics 2005, 6:3 61 5 29 1 http://www.biomedcentral.com/1472-6939/6/3 8 10 80 1 Table 1: Summary of the ethical issues concerning cardiac report cards (adapted from Nast S, Richard SA, Martin DK. Ethical issues 8 11 19 1 related to cardiac report cards. 28 11 24 1 Cardiol. Mar 1 2004;20(3):325–328.... | 1,000 | 771 | |
8 5 17 1 BMC Genomics 2005, 6:39 60 5 30 1 http://www.biomedcentral.com/1471-2164/6/39 8 10 48 1 Results bacterial growth [5]. In contrast, most organisms contain 8 12 53 1 The Rpf domain several rpf-like genes, whose products are functionally 8 13 81 1 Bacterial genome sequencing projects have uncovered redundant [3,6... | 1,000 | 771 | |
8 5 17 1 BMC Genomics 2005, 6:39 60 5 30 1 http://www.biomedcentral.com/1471-2164/6/39 10 13 9 1 S. coelicolor 49 13 2 0 tatD 41 13 37 1 ksgA sco3152 62 13 2 0 rpfB 11 17 10 1 C. glutamicum 49 17 2 0 tatD 34 17 41 1 ksgA cgl0883 61 17 2 0 rpfB 11 20 11 1 M. tuberculosis 35 21 2 0 metS 48 21 2 0 tatD 61 21 13 0 ksgA rpf... | 1,000 | 771 | |
8 5 16 1 BMC Pediatrics 2005, 5:4 61 5 29 1 http://www.biomedcentral.com/1471-2431/5/4 8 10 28 1 Table 1: Details of tests evaluated in the review 9 12 2 1 Test 29 12 4 1 Details 50 12 7 1 Advantages 70 12 9 1 Disadvantages 9 15 9 1 Urine sampling 29 18 14 1 Needle attached to syringe 50 18 14 1 Least risk of contamina... | 1,000 | 771 | |
8 5 16 1 BMC Pediatrics 2005, 5:4 61 5 29 1 http://www.biomedcentral.com/1471-2431/5/4 23 12 8 1 Withdrawals 83 12 2 1 Yes 83 14 2 1 No 16 15 15 1 Uninterpretable results 83 16 7 1 Not stated 18 17 13 1 Clinical review bias 16 20 15 1 Diagnostic review bias 20 22 11 1 Test review bias 13 25 18 1 Reference execution det... | 1,000 | 771 |
End of preview. Expand in Data Studio
README.md exists but content is empty.
- Downloads last month
- 5